• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体 γ 参与大麻素类化合物对肝癌的抗肿瘤作用。

Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.

机构信息

Biochemistry and Molecular Biology Unit, Department of System Biology, School of Medicine, University of Alcala, Madrid, Spain.

出版信息

Cell Death Dis. 2013 May 2;4(5):e618. doi: 10.1038/cddis.2013.141.

DOI:10.1038/cddis.2013.141
PMID:23640460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3674350/
Abstract

Cannabinoids exert antiproliferative effects in a wide range of tumoral cells, including hepatocellular carcinoma (HCC) cells. In this study, we examined whether the PPARγ-activated pathway contributed to the antitumor effect of two cannabinoids, Δ9-tetrahydrocannabinol (THC) and JWH-015, against HepG2 and HUH-7 HCC cells. Both cannabinoids increased the activity and intracellular level of PPARγ mRNA and protein, which was abolished by the PPARγ inhibitor GW9662. Moreover, genetic ablation with small interfering RNA (siRNA), as well as pharmacological inhibition of PPARγ decreased the cannabinoid-induced cell death and apoptosis. Likewise, GW9662 totally blocked the antitumoral action of cannabinoids in xenograft-induced HCC tumors in mice. In addition, PPARγ knockdown with siRNA caused accumulation of the autophagy markers LC3-II and p62, suggesting that PPARγ is necessary for the autophagy flux promoted by cannabinoids. Interestingly, downregulation of the endoplasmic reticulum stress-related protein tribbles homolog 3 (TRIB3) markedly reduced PPARγ expression and induced p62 accumulation, which was counteracted by overexpression of PPARγ in TRIB3-knocked down cells. Taken together, we demonstrate for the first time that the antiproliferative action of the cannabinoids THC and JWH-015 on HCC, in vitro and in vivo, are modulated by upregulation of PPARγ-dependent pathways.

摘要

大麻素在广泛的肿瘤细胞中发挥抗增殖作用,包括肝癌 (HCC) 细胞。在这项研究中,我们研究了两种大麻素 Δ9-四氢大麻酚 (THC) 和 JWH-015 的 PPARγ 激活途径是否有助于它们对 HepG2 和 HUH-7 HCC 细胞的抗肿瘤作用。这两种大麻素都增加了 PPARγ mRNA 和蛋白的活性和细胞内水平,而这一作用被 PPARγ 抑制剂 GW9662 所阻断。此外,小干扰 RNA (siRNA) 的基因敲除以及 PPARγ 的药理学抑制作用降低了大麻素诱导的细胞死亡和细胞凋亡。同样,GW9662 完全阻断了大麻素在荷瘤 HCC 小鼠模型中的抗肿瘤作用。此外,siRNA 下调 PPARγ 导致自噬标记物 LC3-II 和 p62 的积累,表明 PPARγ 是大麻素促进的自噬通量所必需的。有趣的是,内质网应激相关蛋白 tribbles 同源物 3 (TRIB3) 的下调显著降低了 PPARγ 的表达并诱导了 p62 的积累,而在 TRIB3 敲低细胞中过表达 PPARγ 则逆转了这一现象。总之,我们首次证明了大麻素 THC 和 JWH-015 在 HCC 中的体外和体内的抗增殖作用是通过上调 PPARγ 依赖性途径来调节的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/7c9cfd9a1330/cddis2013141f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/2a9ed76f5141/cddis2013141f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/47d1e17fbd07/cddis2013141f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/4eafe628566b/cddis2013141f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/5b3bc4f8d1b5/cddis2013141f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/f965b22e19e9/cddis2013141f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/c9a0cec589e8/cddis2013141f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/7c9cfd9a1330/cddis2013141f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/2a9ed76f5141/cddis2013141f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/47d1e17fbd07/cddis2013141f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/4eafe628566b/cddis2013141f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/5b3bc4f8d1b5/cddis2013141f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/f965b22e19e9/cddis2013141f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/c9a0cec589e8/cddis2013141f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92b/3674350/7c9cfd9a1330/cddis2013141f7.jpg

相似文献

1
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.过氧化物酶体增殖物激活受体 γ 参与大麻素类化合物对肝癌的抗肿瘤作用。
Cell Death Dis. 2013 May 2;4(5):e618. doi: 10.1038/cddis.2013.141.
2
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.大麻素类化合物对肝细胞癌的抗肿瘤作用:AMPK 依赖性自噬激活的作用。
Cell Death Differ. 2011 Jul;18(7):1099-111. doi: 10.1038/cdd.2011.32. Epub 2011 Apr 8.
3
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.过氧化物酶体增殖物激活受体γ(PPARγ)的激活通过下调SEPT2表达来抑制肝癌细胞生长。
Cancer Lett. 2015 Apr 1;359(1):127-35. doi: 10.1016/j.canlet.2015.01.004. Epub 2015 Jan 12.
4
Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.汉黄芩素通过 AMPK 和 ERK 信号通路介导的 PPARγ 激活抑制肝癌生长和转移。
Biomed Pharmacother. 2018 Jul;103:272-283. doi: 10.1016/j.biopha.2018.04.014. Epub 2018 Apr 24.
5
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.合成大麻素WIN诱导HepG2细胞凋亡:转录因子PPARγ的作用
Biochimie. 2009 Apr;91(4):457-65. doi: 10.1016/j.biochi.2008.11.003. Epub 2008 Nov 27.
6
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.自噬抑制增强多激酶抑制剂索拉非尼对肝癌的抗肿瘤作用。
Int J Cancer. 2012 Aug 1;131(3):548-57. doi: 10.1002/ijc.26374. Epub 2011 Sep 12.
7
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.WIN 通过依赖于 PPARγ 下调的自噬流阻滞诱导人结肠癌细胞发生凋亡性细胞死亡。
Apoptosis. 2014 Jun;19(6):1029-42. doi: 10.1007/s10495-014-0985-0.
8
15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.15-PGDH 通过 15-酮-PGE2/PPARγ 介导的 p21WAF1/Cip1 激活抑制肝细胞癌生长。
Oncogene. 2014 Feb 27;33(9):1101-12. doi: 10.1038/onc.2013.69. Epub 2013 Apr 1.
9
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.一种过氧化物酶体增殖物激活受体γ拮抗剂可诱导波形蛋白裂解并抑制高级别肝细胞癌的侵袭。
Oncol Rep. 2007 Oct;18(4):825-32.
10
Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.色素性干皮病 D 组通过 PPARγ 通路下调 ERG 表达抑制 HepG2 细胞增殖并促进其凋亡。
Int J Exp Pathol. 2021 Jun;102(3):157-162. doi: 10.1111/iep.12396. Epub 2021 May 15.

引用本文的文献

1
Cannabidiol (CBD) as a potential therapeutic agent for liver cancer: a comprehensive review of current evidence.大麻二酚(CBD)作为肝癌的潜在治疗药物:当前证据的综合综述
Cancer Cell Int. 2025 Jun 18;25(1):215. doi: 10.1186/s12935-025-03870-3.
2
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy.大麻素对接受免疫检查点抑制剂免疫治疗的患者癌症预后的影响。
Front Immunol. 2025 Mar 5;16:1497829. doi: 10.3389/fimmu.2025.1497829. eCollection 2025.
3
Decoding the Postulated Entourage Effect of Medicinal : What It Is and What It Isn't.

本文引用的文献

1
Hepatocellular carcinoma: focus on different aspects of management.肝细胞癌:聚焦于管理的不同方面。
ISRN Oncol. 2012;2012:421673. doi: 10.5402/2012/421673. Epub 2012 May 13.
2
Towards the use of cannabinoids as antitumour agents.朝着将大麻素用作抗肿瘤药物的方向发展。
Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247.
3
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.过氧化物酶体增殖物激活受体γ抑制肝癌细胞在体外和体内的转移。
解读药用植物假定的整体效应:其内涵与非内涵
Biomedicines. 2023 Aug 21;11(8):2323. doi: 10.3390/biomedicines11082323.
4
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.过氧化物酶体增殖物激活受体 α 和 γ 在中脑多巴胺神经元中表达,并调节小鼠中多巴胺和大麻素介导的行为。
Mol Psychiatry. 2023 Oct;28(10):4203-4214. doi: 10.1038/s41380-023-02182-0. Epub 2023 Jul 21.
5
The endocannabinoid system and breathing.内源性大麻素系统与呼吸。
Front Neurosci. 2023 Apr 18;17:1126004. doi: 10.3389/fnins.2023.1126004. eCollection 2023.
6
NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genes.NLRC5影响雌性小鼠饮食诱导的肥胖,并共同调节过氧化物酶体增殖物激活受体PPARγ靶基因。
iScience. 2023 Mar 2;26(4):106313. doi: 10.1016/j.isci.2023.106313. eCollection 2023 Apr 21.
7
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.过氧化物酶体增殖物激活受体α(PPARα)和过氧化物酶体增殖物激活受体γ(PPARγ)在中脑多巴胺能神经元中表达,并调节小鼠中多巴胺和大麻素介导的行为。
Res Sq. 2023 Mar 2:rs.3.rs-2614714. doi: 10.21203/rs.3.rs-2614714/v1.
8
Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review.大麻二酚对炎症和癌症中细胞凋亡及自噬的调节作用综述
Front Pharmacol. 2023 Jan 23;14:1094020. doi: 10.3389/fphar.2023.1094020. eCollection 2023.
9
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.大麻素化合物作为治疗非癌症皮肤疾病的一种药物治疗选择。
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.
10
Cys-loop receptors on cannabinoids: All high?大麻素上的半胱氨酸环受体:全都兴奋吗?
Front Physiol. 2022 Nov 9;13:1044575. doi: 10.3389/fphys.2022.1044575. eCollection 2022.
Br J Cancer. 2012 Apr 24;106(9):1486-94. doi: 10.1038/bjc.2012.130.
4
Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells.激活的 AMPK 可抑制肝癌细胞中 PPAR-α 和 PPAR-γ 的转录活性。
Am J Physiol Gastrointest Liver Physiol. 2011 Oct;301(4):G739-47. doi: 10.1152/ajpgi.00432.2010. Epub 2011 Jun 23.
5
Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis.过氧化物酶体增殖物激活受体 γ 通过诱导组织蛋白酶 L 诱导人单核细胞源性巨噬细胞凋亡和抑制自噬:在动脉粥样硬化中的潜在作用。
J Biol Chem. 2011 Aug 19;286(33):28858-28866. doi: 10.1074/jbc.M111.273292. Epub 2011 Jun 23.
6
Peroxisome proliferator-activated receptor γ-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.过氧化物酶体增殖物激活受体 γ 调控的组织蛋白酶 D 是树突状细胞呈递脂质抗原所必需的。
J Immunol. 2011 Jul 1;187(1):240-7. doi: 10.4049/jimmunol.1002421. Epub 2011 Jun 1.
7
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.大麻素类化合物对肝细胞癌的抗肿瘤作用:AMPK 依赖性自噬激活的作用。
Cell Death Differ. 2011 Jul;18(7):1099-111. doi: 10.1038/cdd.2011.32. Epub 2011 Apr 8.
8
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.过氧化物酶体增殖物激活受体与癌症:挑战与机遇。
Br J Pharmacol. 2011 Sep;164(1):68-82. doi: 10.1111/j.1476-5381.2011.01383.x.
9
The endocannabinoid system and cancer: therapeutic implication.内源性大麻素系统与癌症:治疗意义。
Br J Pharmacol. 2011 Aug;163(7):1447-63. doi: 10.1111/j.1476-5381.2011.01327.x.
10
Advanced hepatocellular carcinoma. Review of targeted molecular drugs.晚期肝细胞癌。靶向分子药物综述。
Ann Hepatol. 2011 Jan-Mar;10(1):21-7.